Is Select Medical Holdings (SEM) overvalued? · P/E 15, rev $1.31B
Select Medical Holdings (SEM) is a medical care facilities company listed on NYSE.
This page asks whether Select Medical Holdings (SEM) looks expensive on cached numbers — not a short thesis.
Latest reported SEM revenue for 2024-12-31 was $1.31B. Net income was $3.8M. Revenue was up 3.2% from 2024-09-30 to 2024-12-31. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
SEM currently screens at market cap $2.05B and trailing P/E 15.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SEM 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SEM stock page for the full model, not this heading.
Not investment advice.